Hydrochloric Acid

Hydrochloric Acid

SCHEMBL5484769

Cc1c(Cl)cc(NC(=O)Cn2cc[n+](C)c2)c(O)c1Cl.[Cl-]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.42
LMNA P02545 4/20 0.42
MAPK1 P28482 3/20 0.42
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.37
ALDH1A1 P00352 4/20 0.36
TSHR P16473 1/20 0.36
MAPT P10636 1/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
POLB P06746 2/20 0.33
ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6941327 0.99 HPGD (0.43) HPGDLMNAMAPK1HTTSMN1; SMN2
Hydrochloric Acid SCHEMBL6943653 0.88 HPGD (0.36) HPGDLMNAMAPK1HTTSMN1; SMN2
Hydrochloric Acid SCHEMBL6573781 0.87 MAPK1 (0.40) HPGDLMNAMAPK1HTTALDH1A1
SCHEMBL6944219 0.86 HPGD (0.37) HPGDLMNAMAPK1HTTSMN1; SMN2
Hydrochloric Acid SCHEMBL6942108 0.86 HPGD (0.35) HPGDLMNAMAPK1HTTSMN1; SMN2
SCHEMBL6572970 0.85 HPGD (0.41) HPGDLMNAMAPK1HTTALDH1A1
SCHEMBL6946387 0.84 HPGD (0.36) HPGDLMNAMAPK1HTTSMN1; SMN2
Hydrochloric Acid SCHEMBL6944858 0.84 ALDH1A1 (0.36) HPGDLMNAMAPK1HTTSMN1; SMN2
Hydrochloric Acid SCHEMBL6940892 0.84 HPGD (0.43) HPGDLMNAMAPK1HTTSMN1; SMN2
SCHEMBL6946291 0.83 ALDH1A1 (0.36) HPGDLMNAMAPK1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1066022-B1 COMPOSITIONS FOR OXIDATION DYEING KERATIN FIBRES COMPRISING A CATIONIC COUPLER, NOVEL CATIONIC COUPLERS, THEIR USE FOR OXIDATION DYEING AND DYEING METHODS OREAL (FR) 2003-10-22 EP claimed
US-6544298-B1 Dyeing human hair using coupler L'OREAL (FR) 2003-04-08 US claimed
US-20070226917-A1 Hair Dye Agent Comprising Organosilicon Copolymers with Amino Groups and Polyoxyalkylene Groups and Use Thereof HENKEL KGAA (DE) 2007-10-04 US disclosed
US-7179303-B2 Active ingredient combinations for hair-dyeing agents HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 2007-02-20 US disclosed
US-20040133996-A1 Active ingredient combinations for hair-dyeing agents HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2004-07-15 US disclosed
US-20040064901-A1 Enzymatic coloring agents HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 2004-04-08 US disclosed
US-6544298-B1 Dyeing human hair using coupler L'OREAL (FR) 2003-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040133996-A1 Active ingredient combinations for hair-dyeing agents KRT18, COL1A1, MKI67 HPGD 388/4885LMNA 114/4885MAPK1 166/4885
US-20040064901-A1 Enzymatic coloring agents GLA, HEXA, HSD17B14 HPGD 1449/4885LMNA 1279/4885MAPK1 2029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.